| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.086 | 0.06 |